Actively Recruiting
IBD Registry in a Sub-Saharan African Population
Led by University of Zimbabwe · Updated on 2024-07-11
100
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
U
University of Zimbabwe
Lead Sponsor
S
Swiss IBDnet
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.
CONDITIONS
Official Title
IBD Registry in a Sub-Saharan African Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with confirmed inflammatory bowel disease
- Disease onset at least 3 months ago
- Controls aged 18 years or older
- Controls include one sibling or cousin and one neighbor of the patient
You will not qualify if you...
- Controls with suspected inflammatory bowel disease
- Controls with unexplained gastrointestinal symptoms such as diarrhea, vomiting, chronic abdominal pain, weight loss, rectal bleeding, or recent bowel habit changes
- Controls with previous unexplained gastrointestinal surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Parirenyatwa Hospital
Harare, Zimbabwe
Actively Recruiting
Research Team
L
Leolin Katsidzira, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here